RE:RE:RE:RE:New Press Release - Dundee Corporation Announces the Sale of 8,000 Shares of TauRx Pharmaceuticals Ltd. for Proceeds of US$1 MillionI think is smart to take some chips of the table. Maybe a bit more, but I think the key point is this is the first time in a while we get to see what the market value for the investment is. They hold Taurx at $68M cad or 0.78 a share. This US$1M investment translates into a cad$170m valuation which is $1.9 a share. With the regulatory approvals this could go to 0 or it could go to $500m so is an interesting snapshot in time of where we are and makes it so clear how undervalued the stock is.